AI Speeds Up Drug Discovery Revolution

The pharma world is buzzing as AI slashes drug discovery from 5 years to just 1. Insitro, launched in 2018 by Daphne Koller, is leading the charge by crunching vast datasets to target complex diseases. With 80% of pharma pros on board and investments topping $5.2B, collaboration between engineers and life scientists is key. AI-driven clinical trials are saving up to 70% in costs. Despite challenges like data biases, the future looks bright and a bit more algorithmic!